Antiviral Drug Market - Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2029
Overview
Antiviral Drug Market size was valued at US$ 64.39 Bn. in 2021 and the total revenue is expected to grow at CAGR 4.2% through 2021 to 2029, reaching nearly US$ 89.49 Bn.
Antiviral Drug Market Overview:
Antiviral drugs are used to treat viral infections and act by inhibiting their target viruses. The growth of antiviral drug market is driven by a factor such as a rise in healthcare expenditure, growing research and development investment. The emergence of life treating diseases like bird flu, strong development pipeline, and increasing incidence rates of viral infections particularly HIV. In 2019 WHO estimates that approximately, 36.7 million people are suffering from HIV/AIDS worldwide with 1.1 million deaths of AIDS-related illnesses. Thanks to government initiatives towards awareness about HIV-like infection, it’s also contributing to the growth of the market.
To know about the Research Methodology :- Request Free Sample Report
The increasing prevalence of viral infections such as HIV, influenza, herpes, hepatitis, and other viral infections, as well as developments in antiviral drug R&D, rising strategic initiatives for the antiviral drugs market, and developing healthcare infrastructure in emerging economies, are all major drivers boosting the global antiviral drugs treatment market. Over the forecast period, a primary element driving demand for antiviral medications is the rising incidence of viral illness over the world.
According to the WHO, an estimated 325 million individuals worldwide have hepatitis, with 71 million of these having chronic hepatitis C virus infection. Furthermore, the United States Department of Health and Human Services estimates that 2.4 million people in the country have hepatitis C, with approximately 850,000 people infected with hepatitis B.
Antiviral medications are being developed as a result of research and development in the field of viral illnesses. Increased investment in the field of antiviral medications, owing to its multiple benefits, has resulted in the emergence of new chances for laboratory research. Antiviral medications help to shorten the duration of flu symptoms and are recommended for both flu therapy and prevention. The medications may also lower the incidence of consequences such as antibiotic-resistant respiratory infections in children, ear infections in adults, and hospitalization in adults. The rising number of HIV cases around the world is a primary factor driving market revenue growth. According to the World Health Organization (WHO), approximately 34.7 million people will be infected with HIV by 2021.
Antiviral Drug Market Segment Analysis:
The Antiviral Drug Market is segmented based on Drug Class Drug Type and Application.
Based on the Drug Class, The Antiviral Drug Market is segmented into DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, The Reverse Transcriptase Inhibitors segment is dominated the market and held the largest market share of 49.0% in the year 2021. Increasing the diagnosis and treatment rate of HIV cases, as this medicine is mainly used to treat HIV infection and high effectiveness of these drugs against viral infections rising the market growth.
Based on the Drug Type, The Antiviral Drug Market is segmented into Branded Generics. The branded segment dominated the Antiviral Drug Market and held the largest market share of 57.2% in the year 2021. The high adoption rate of branded drugs in North America and the European markets and the high cost of drugs is expected to drive the segment.
Based on the Application, The Antiviral Drug Market is segmented into HIV, Hepatitis, Herpes, Influenza, Others. The HIV segment dominated the market with the largest market share of 44.6% in the year 2021. The high prevalence of HIV infection and its treatment has been rising the demand for the branded drugs in the market. Government initiatives and drug development technology also increase the treatment rate and are estimated to drive the Antiviral Drug Market.
Antiviral Drug Market Regional Insights:
North America dominated the Antiviral Drug Market with the largest market share of 53 % in 2021. It is also expected to register a CAGR of 4.1% during the forecast period. Increase in prevalence of neurological disease and increasing geriatric population, because this disease mostly occurs in the old age people. The loss of market exclusivity for branded pharmaceuticals, rising vaccination rates against viral diseases, and government initiatives to lower the frequency of viral infections are all contributing to the market downturn. For example, the United States government is adopting a number of steps, including investing in infectious disease programs and boosting R&D initiatives for novel viral infection medicines.
Presence of well-established healthcare infrastructure and favorable government initiatives for the healthcare system. The presence of high drug development technology and skilled professionals has been increased the Antiviral Drug Market in this region.
Asia Pacific is expected to grow the market with a CAGR of 3.9% during the forecast period. As rising disposable income level and the favorable healthcare government initiative in emerging economies such as India, China, and Japan. Rising government funding and support to improve drug development and innovative technology in it are also increasing the market revenue in this region.The objective of the report is to present a comprehensive analysis of the Antiviral Drug Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The reports also helps in understanding the Antiviral Drug Market dynamic, structure by analyzing the market segments and project the Antiviral Drug Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Antiviral Drug Market make the report investor’s guide.
Antiviral Drug Market Scope: Inquire before buying
| Global Antiviral Drug Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2021 | Forecast Period: | 2022-2029 |
| Historical Data: | 2017 to 2021 | Market Size in 2021: | US $ 64.39 Bn. |
| Forecast Period 2022 to 2029 CAGR: | 4.2% | Market Size in 2029: | US $ 89.49 Bn. |
| Segments Covered: | by Drug Class | • DNA Polymerase Inhibitors • Reverse Transcriptase Inhibitors • Protease Inhibitors • Neuraminidase Inhibitors |
|
| by Drug Type | •Branded •Generic |
||
| by Application | • HIV • Hepatitis • Herpes • Influenza |
||
Antiviral Drug Market, by Region
• North America
• Europe
• Asia Pacific
• South America
• Middle East and Africa
Antiviral Drug Market Key Players
• Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc
• AbbVie
• Merck & Co., Inc.
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Cipla Inc.
• Aurobindo Pharma
• Dr. Reddy’s Laboratories Ltd.
• GlaxoSmithKline PLC
• Eisai Co. Ltd.
• Pfizer Inc.
• Medtronic PLC
• UCB SA
• NeuroPace Inc.
• GW Pharmaceuticals PLC
• Novartis AG
• Johnson & Johnson Services Inc.
• Abbott Laboratories
• DiaGenic ASA
• Quanterix
Frequently Asked Questions:
1] Which segments are covered in Antiviral Drug Market report?
Ans. The segments covered in Antiviral Drug Market report are based on by Drug Class Drug Type and Application.
2] Which region is expected to hold the highest share in the Antiviral Drug Market?
Ans. North America is expected to hold the highest share in the Antiviral Drug Market
3] What is the market size of Antiviral Drug Market by 2029?
Ans. The market size of Antiviral Drug Market by 2029 is US $ 89.49Bn.
4] Who are the top key players in the Antiviral Drug Market?
Ans. Hoffmann-La Roche Ltd. GlaxoSmithKline plc, Abbie, Merck & Co., Inc., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Cipla Inc., Aurobindo Pharma, bDr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC
5] What was the market size of Antiviral Drug Market in 2021?
Ans. The market size of Antiviral Drug Market in 2021 was US $ 64.39 Bn